<DOC>
	<DOCNO>NCT01214395</DOCNO>
	<brief_summary>This study compare use tea tree oil topical nasal antiseptic prevent infection patient need renal dialysis . A maximum fifty subject recruit assessed sign infection per week first 6 week every 4 week week 26 . They also check nasal carriage 'Golden Staph ' enroll trial . The subject complete trial 26 week infection-free infection period</brief_summary>
	<brief_title>Nasal Tea Tree Oil Prevention Infections PD Patients</brief_title>
	<detailed_description>The patient trial recruit Renal Unit SCGH enrolment nasal swab take see patient nasal carriage S. aureus . The patient also give prescription 5 % TTO nasal ointment fill SCGH pharmacy . The application medication follow usual procedure consist bi-daily nasal application 5 day weekly application next 25 week trial . The patient blind give medication one dispensing consist 3 Ã— 10 g tube 5 % TTO . The patient weekly assessment first 6 week trial 4 weekly assessment week 26 . All assessment conduct routine dressing change routine visit conduct specially trained dialysis nurse . During visit catheter site examine sign infection finding document questionnaire . Suspected case infection identify trained nurse consultant physician examine patient . The finding document nurse questionnaire submit primary investigator review , confirmation , classification . The primary endpoint proportion patient catheter-related infection within 6 month entry study . The infection include : ( 1 ) exit site infection ( ESI ) ; ( 2 ) tunnel infection ; ( 3 ) bacteraemia . The endpoint evaluate primary investigator accord definition catheter-related infection . Cases `` definite '' `` probable '' infection classify infection . All catheter-related infection treat patient 's nephrologist accord usual practice . If new catheter clinically indicate , patient continue receive ointment assign . Swabs culture sensitivity catheter exit site take exit tunnel infection suspect blood culture bacteraemia suspect . All microbiology sample send PathWest laboratory culture sensitivity . The study end last enrolled subject complete minimum 6-month study period .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Tea Tree Oil</mesh_term>
	<criteria>Men woman 18 year age A sign date write informed consent obtain prior participation . Able comply requirement protocol . Have ESRD dialysis plan Requirement either haemodialysis peritoneal dialysis know sensitivity TTO Use mediate nonmedicated nasal ointment past 12 week HD patient likely transfer another dialysis centre next 6 month Reinsertion CVC serious , uncontrolled disease ( include serious psychological disorder ) likely interfere study and/or likely cause death within study duration participation another clinical trial last 12 week previous participation trial know contraindication component mupirocin concurrent disease exclude administration therapy outline study protocol active infection require systemically administer antibiotic antiviral medication within last 7 day acute renal failure noncompensated heart failure myocardial infarction last 6 month chronic lung disease hypoxemia severe noncompensated hypertension severe noncompensated diabetes mellitus know HIV active chronic hepatitis B C infection subject , opinion investigator , likely complete study ever reason . subject , opinion investigator , abuse alcohol drug subject clinically significant abnormality ( determined investigator ) follow review screen laboratory data full physical examination . Stable medical condition unlikely affect patient safety outcome investigation may acceptable agreed study monitor appoint sponsor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>haemodialysis</keyword>
	<keyword>peritoneal dialysis</keyword>
</DOC>